Biofrontera (NASDAQ:BFRI) has achieved a significant clinical milestone, announcing that its Phase 3 trial of Ameluz® photodynamic therapy (PDT) met its primary endpoint for the treatment of mild-to-moderate actinic keratoses (AK) located on the extremities, neck, and trunk.
Autodesk (NASDAQ:ADSK) has initiated a high-stakes legal battle against Alphabet (NASDAQ:GOOGL), filing a trademark infringement lawsuit in San Francisco federal court on February 6, 2026.
Telehealth provider Hims & Hers Health (NYSE:HIMS) transitioned from a marketing high to a legal defense on February 9, 2026, as Danish pharmaceutical giant Novo Nordisk (NYSE:NVO) filed a lawsuit alleging patent infringement and deceptive marketing
Alexander’s (NYSE:ALX) reported a steep decline in financial performance for the final quarter of 2025, with both net income and funds from operations (FFO) falling well below prior-year levels.
In times of uncertainty, we often look for something solid to hold onto. Lately, it seems the world’s investors have decided that “something solid” is, quite literally, gold.
The metal’s soaring price is more than just a market trend; it's a global barometer of anxiety.
When faith in currencies, governments, and traditional financial systems begins to waver, we see a familiar flight to the perceived safety of this timeless asset.
Well, pull out the party hats and dust off the stock tickers.
Lithium, the commodity that investors and analysts had all but left for dead in the great market purge of 2023-2024, is back.
The stock market has long treated Tesla (NASDAQ:TSLA) less as a traditional automaker and more as a futuristic technology cult, with its valuation soaring on the gravitational pull of its CEO, Elon Musk.
This persistent "Musk Premium" has burned countless short-sellers.
Bitcoin has vaporised more than US$800 billion in its latest crash and sucked US$1 trillion out of the broader crypto market.
With nearly US$2 trillion in market value and rising allocations from Wall Street firms, ETFs, pension funds, and insurers, Bitcoin is increasingly woven into traditional finance.
Trump used his Davos speech to tout US economic dominance, promote crypto, and revive his push for Greenland.
Japan’s bond market has been sliding all week, with the 10-year yield now near 2.37% and the 40-year pushing above 4.2%, both multi-decade highs.
U.S. President Donald Trump has escalated his confrontation with European leaders on the eve of the World Economic Forum in Davos, threatening to impose a 200% tariff on French wine and champagne.
Novo Nordisk (NYSE:NVO) shares rebounded in Frankfurt on Monday after telehealth provider Hims & Hers Health (NYSE:HIMS) abruptly scrapped the launch of a low-cost, compounded weight-loss pill following an aggressive regulatory warning from the U.S. Food and Drug Administration.
Loews (NYSE:L) capped a strong fiscal 2025 with a significant jump in annual net income, driven by robust performance at its insurance subsidiary CNA Financial and a strategic multi-billion dollar share repurchase program.
CNA Financial (NYSE:CNA) delivered a record-breaking performance for 2025, as the commercial insurer’s disciplined underwriting and robust investment gains paved the way for a massive capital return to investors.
Monday.com (NASDAQ:MNDY) shares plunged more than 13% Monday after the work-management platform issued a cautious revenue forecast for 2026, signaling a potential slowdown in the enterprise software sector despite a strong finish to the year.
Hain Celestial Group (NASDAQ:HAIN) reported a wider net loss for its fiscal second quarter on Monday, as a double-digit collapse in snack sales and a massive impairment charge overshadowed modest revenue gains in its beverage and tea business.
Sally Beauty Holdings (NYSE:SBH) kicked off its fiscal year with a double-digit rise in adjusted earnings, prompting the professional beauty leader to raise the lower end of its full-year profit guidance despite a cautious consumer environment.
Indianapolis-based Eli Lilly and Company (NYSE:LLY) announced on February 9, 2026, that it has agreed to acquire Orna Therapeutics, a biotechnology company pioneering circular RNA and novel lipid nanoparticle (LNP) delivery technologies for in vivo cell therapies.
Motorcar Parts of America (NASDAQ:MPAA) reported a dip in third-quarter revenue on Monday, as a major customer’s store closures and distribution center consolidations created a temporary headwind for the automotive aftermarket supplier.
-640x360.jpg&w=1200&q=75)
-640x360.jpg&w=1200&q=75)
